Research Progress in the Role of Tim3/galectin-9 in Hematological Malignancy--Review / 中国实验血液学杂志
Dong-Qin YANG; Yu-Mei ZHANG; Ling-Yun WU; Dong WU; Chun-Kang CHANG.
Journal of Experimental Hematology
; (6): 1360-1364, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-888567
The incidence of hematological malignant tumor is increasing year by year, and seriously affecting the human health. In addition to the traditional radiation and chemotherapy, immunotherapy has achieved a certain effect in the treatment of blood tumor, but it is limited by exhaustion of CD8
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados